In the News
Analyzing the influence of key factors for patient willingness to participate in decentralized clinical trials
Keri Henderson discusses why patients are more willing to participate in a clinical trial if it is offered remotely.
CRO industry report
Our subject matter experts comment on growth areas in outsourcing and the challenges in today’s market.
Aligning patient burden with planetary burden
The authors discuss how making trial participation easier can reduce the impact on the environment.
In focus: Amid heightened industry rules on sustainability, how are CROs faring?
Michael Cohen takes a look at the progress CROs are making in their sustainability efforts.
AI and real-world data integration: Transforming clinical trials and drug development – panel at DIA Global
Our experts delve into the integration of real-world data and advanced technologies to accelerate drug development.
Breaking barriers: Strategic use of FSP models to expand trials into non-footprint countries
Lisa Beckel discusses how leveraging functional service provider models can enhance global clinical trial reach and inclusion.
From Hematologic to Autoimmune Disease – The CAR-T Therapy Second Revolution
CAR-T therapy has entered a new era with its potential application in autoimmune, metabolic and other chronic conditions. Davide Garrisi and Kim Watanabe explore how CAR-T therapy is poised to make a significant impact on patients' lives.
Five critical elements for maximizing functional service partnerships
As organizations look more to functional service partnership models to outsource specific functions of clinical trials, the authors discuss five keys to successfully implementing those relationships.
Beat the clock: How an FSP model can optimize a follow-the-sun approach in clinical development functions
Our experts discuss how a follow-the-sun model delivered in a flexible functional service provider outsourcing model is being used to respond to more challenging timelines.
